nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.07.2014 | Guidelines

The EANM clinical and technical guidelines for lymphoscintigraphy and sentinel node localization in gynaecological cancers

verfasst von: Francesco Giammarile, M. Fani Bozkurt, David Cibula, Jaume Pahisa, Wim J. Oyen, Pilar Paredes, Renato Valdes Olmos, Sergi Vidal Sicart

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

The accurate harvesting of a sentinel node in gynaecological cancer (i.e. vaginal, vulvar, cervical, endometrial or ovarian cancer) includes a sequence of procedures with components from different medical specialities (nuclear medicine, radiology, surgical oncology and pathology). These guidelines are divided into sectione entitled: Purpose, Background information and definitions, Clinical indications and contraindications for SLN detection, Procedures (in the nuclear medicine department, in the surgical suite, and for radiation dosimetry), and Issues requiring further clarification. The guidelines were prepared for nuclear medicine physicians. The intention is to offer assistance in optimizing the diagnostic information that can currently be obtained from sentinel lymph node procedures. If specific recommendations given cannot be based on evidence from original scientific studies, referral is made to “general consensus” and similar expressions. The recommendations are designed to assist in the practice of referral to, and the performance, interpretation and reporting of all steps of the sentinel node procedure in the hope of setting state-of-the-art standards for high-quality evaluation of possible metastatic spread to the lymphatic system in gynaecological cancer. The final result has been discussed by a group of distinguished experts from the EANM Oncology Committee and the European Society of Gynaecological Oncology (ESGO). The document has been endorsed by the SNMMI Board.

Keshtgar MRS, Ell PJ. Sentinel lymph node detection and imaging. Eur J Nucl Med. 1999;26:57–67.PubMed

Cabanas RM. Anatomy and biopsy of sentinel lymph nodes. Urol Clin North Am. 1992;19:267–76.PubMed

Krag DN, Weaver D, Alex JC, Fairbank JT. Surgical resection and radiolocalization of sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2:335–9.PubMed

Benson JR, Della Rovere GQ; Axilla Management Consensus Group. Management of the axilla in women with breast cancer. Lancet Oncol. 2007;8:331–48.PubMed

Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.PubMed

Stehman FB, Bundy BN, DiSaia PJ, Keys HM, Larson JE, Fowler WC. Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer. 1991;67:2776–85.PubMed

Macdonald OK, Chen J, Dodson M, Lee CM, Gaffney DK. Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix. Am J Clin Oncol. 2009;32:411–6.PubMed

Zarganis P, Kondi-Pafiti A, Arapantoni-Dadioti P, Trivizaki E, Velentzas K, Vorgias G, et al. The sentinel node in cervical cancer patients: role of tumor size and invasion of lymphatic vascular space. In Vivo. 2009;23:469–73.PubMed

Elliott P, Coppleson M, Russell P, Liouros P, Carter J, MacLeod C, et al. Early invasive (FIGO stage IA) carcinoma of the cervix: a clinico-pathologic study of 476 cases. Int J Gynecol Cancer. 2000;10:42–52.PubMed

10.

Sakuragi N, Satoh C, Takeda N, Hareyama H, Takeda M, Yamamoto R, et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer. 1999;85:1547–54.PubMed

11.

Lai CH, Chang HC, Chang TC, Hsueh S, Tang SG. Prognostic factors and impacts of adjuvant therapy in early-stage cervical carcinoma with pelvic node metastases. Gynecol Oncol. 1993;51:390–6.PubMed

12.

Rogers LJ, Luesley DM. Stage IA2 cervical carcinoma: how much treatment is enough? Int J Cancer. 2009;19:1620–4.

13.

Benedetti-Panici P, Maneschi F, Scambia G, Greggi S, Cutillo G, D'Andrea G, et al. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol. 1996;62:19–24.PubMed

14.

Lea JS, Sheets EE, Duska LR, Miller DS, Schorge JO. Early-stage cervical adenocarcinoma treated by surgical intent: the role of para-aortic lymph node dissection. Gynecol Oncol. 2002;84:285–8.PubMed

15.

Hackett TE, Olt G, Sorosky JI, Podczaski E, Harrison TA, Mortel R. Surgical predictors of para-aortic metastases in early-stage cervical carcinoma. Gynecol Oncol. 1995;59:15–9.PubMed

16.

Bader AA, Winter R, Haas J, Tamussino KF. Where to look for the sentinel lymph node in cervical cancer. Am J Obstet Gynecol. 2007;197:678.e1–7.

17.

Cibula D, Abu-Rustum NR, Dusek L, Zikán M, Zaal A, Sevcik L, et al. Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer. Gynecol Oncol. 2012;124:496–501.PubMed

18.

Cibula D, Abu-Rustum NR, Dusek L, Slama J, Zikán M, Zaal A, et al. Bilateral ultrastaging of sentinel lymph node in cervical cancer: lowering the false-negative rate and improving the detection of micrometastasis. Gynecol Oncol. 2012;127:462–6.PubMed

19.

Hauspy J, Beiner M, Harley I, Ehrlich L, Rasty G, Covens A. Sentinel lymph nodes in early stage cervical cancer. Gynecol Oncol. 2007;105:285–90.PubMed

20.

Cibula D, Kuzel D, Sláma J, Fischerova D, Dundr P, Freitag P, et al. Sentinel node (SLN) biopsy in the management of locally advanced cervical cancer. Gynecol Oncol. 2009;115:46–50.PubMed

21.

Altgassen C, Hertel H, Brandstädt A, Köhler C, Dürst M, Schneider A, et al. Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO Study Group. J Clin Oncol. 2008;26:2943–51.PubMed

22.

Frumovitz M, Ramirez PT, Levenback CF. Lymphatic mapping and sentinel lymph node detection in women with cervical cancer. Gynecol Oncol. 2008;110:S17–20.PubMed

23.

Kushner DM, Connor JP, Wilson MA, Hafez GR, Chappell RJ, Stewart SL, et al. Laparoscopic sentinel lymph node mapping for cervix cancer: a detail evaluation and time analysis. Gynecol Oncol. 2007;106:507–12.PubMed

24.

Fader AN, Edwards RP, Cost M, Kanbour-Shakir A, Kelley JL, Schwartz B, et al. Sentinel lymph node biopsy in early-stage cervical cancer: utility of intraoperative versus postoperative assessment. Gynecol Oncol. 2008;111:13–7.PubMed

25.

Euscher ED, Malpica A, Atkinson EN, Levenback CF, Frumovitz M, Deavers MT. Ultrastaging improves detection of metastases in sentinel lymph nodes of uterine cervix squamous cell carcinoma. Am J Surg Pathol. 2008;32:1336–43.PubMed

26.

Buist MR, Pijpers RJ, van Lingen A, van Diest PJ, Dijkstra J, Kenemans P, et al. Laparoscopic detection of sentinel lymph nodes followed by lymph node dissection in patients with early stage cervical cancer. Gynecol Oncol. 2003;90:290–6.PubMed

27.

van Dam PA, Hauspy J, Vanderheyden T, Sonnemans H, Spaepen A, Eggenstein G, et al. Intraoperative sentinel node identification with technetium-99m-labeled nanocolloid in patients with cancer of the uterine cervix: a feasibility study. Int J Gynecol Cancer. 2003;13:182–6.PubMed

28.

Seong SJ, Park H, Yang KM, Kim TJ, Lim KT, Shim JU, et al. Detection of sentinel lymph nodes in patients with early stage cervical cancer. J Korean Med Sci. 2007;22:105–9.PubMedCentralPubMed

29.

Slama J, Dundr P, Dusek L, Fischerova D, Pinkavova I, Zikan M, et al. Sentinel lymph node status in patients with locally advanced cervical cancers and impact of neoadjuvant chemotherapy. Gynecol Oncol. 2012;125:303–6.PubMed

30.

Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet. 2005;366:491–505.PubMed

31.

Partridge EE, Shingleton HM, Menck HR. The National Cancer Data Base report on endometrial cancer. J Surg Oncol. 1996;61:111–23.PubMed

32.

Gien LT, Kwon JS, Carey MS. Sentinel node mapping with isosulfan blue dye in endometrial cancer. J Obstet Gynaecol Can. 2005;27:1107–12.PubMed

33.

Dzvincuk P, Pilka R, Kudela M, Koranda P. Sentinel lymph node detection using 99mTc-nanocolloid in endometrial cancer. Ceska Gynekol. 2006;71:231–6.PubMed

34.

Altgassen C, Pagenstecher J, Jornung D, Diedrich K, Hornemann A. A new approach to label sentinel nodes in endometrial cancer. Gynecol Oncol. 2007;105:457–61.PubMed

35.

Delaloye JF, Pampallona S, Chardonnens E, Fiche M, Lehr HA, De Grandi P, et al. Intraoperative lymphatic mapping and sentinel node biopsy using hysteroscopy in patients with endometrial cancer. Gynecol Oncol. 2007;106:89–93.PubMed

36.

Delpech Y, Cortez A, Coutant C, Callard P, Uzan S, Darai E, et al. The sentinel node concept in endometrial cancer: histopathologic validation by serial section and immunohistochemistry. Ann Oncol. 2007;18:1799–803.PubMed

37.

Li B, Li XG, Wu LY, Zhang WH, Li SM, Min C, et al. A pilot study of sentinel lymph nodes identification in patients with endometrial cancer. Bull Cancer. 2007;94:E1–4.PubMed

38.

Lopes LA, Nicolau SM, Baracat FF, Baracat EC, Gonçalves WJ, Santos HV, et al. Sentinel lymph node in endometrial cancer. Int J Gynecol Cancer. 2007;17:1113–7.PubMed

39.

Ballester M, Dubernard G, Rouzier R, Barranger E, Darai E. Use of the sentinel node procedure to stage endometrial cancer. Ann Surg Oncol. 2008;15:1523–9.PubMed

40.

Bats AS, Clément D, Larousserie F, Le Frère-Belda MA, Pierquet-Ghazzar N, Hignette C, et al. Does sentinel node biopsy improve the management of endometrial cancer? Data from 43 patients. J Surg Oncol. 2008;97:141–5.PubMed

41.

Clement D, Bats AS, Ghazzar-Pierquet N, Le Frere Belda MA, Larousserie F, Nos C, et al. Sentinel lymph nodes in endometrial cancer: is hysteroscopic injection valid? Eur J Gynaecol Oncol. 2008;29:239–41.PubMed

42.

Perrone AM, Casadio P, Formelli G, Levorato M, Ghi T, Costa S, et al. Cervical and hysteroscopic injection for identification of sentinel lymph node in endometrial cancer. Gynecol Oncol. 2008;111:62–7.PubMed

43.

Abu-Rustum NR, Khoury-Collado F, Pandit-Taskar N, Soslow RA, Dao F, Sonoda Y, et al. Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma? Gynecol Oncol. 2009;113:163–9.PubMedCentralPubMed

44.

Barranger E, Delpech Y, Coutant C, Dubernard G, Uzan S, Darai E. Laparoscopic sentinel node mapping using combined detection for endometrial cancer: a study of 33 cases – is it a promising technique? Am J Surg. 2009;197:1–7.PubMed

45.

Robova H, Charvat M, Strnad P, Hrehorcak M, Taborska K, Skapa P, et al. Lymphatic mapping in endometrial cancer: comparison of hysteroscopic and subserosal injection and the distribution of sentinel lymph nodes. Int J Gynecol Cancer. 2009;19:391–4.PubMed

46.

Mais V, Peiretti M, Gargiulo T, Parodo G, Cirronis MG, Melis GB. Intraoperative sentinel lymph node detection by vital dye through laparoscopy or laparotomy in early endometrial cancer. J Surg Oncol. 2010;101:408–12.PubMed

47.

Hacker NF, Berek JS, Lagasse LD, Leuchter RS, Moore JG. Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet Gynecol. 1983;61:408–12.PubMed

48.

Burger MP, Hollema H, Emanuels AG, Krans M, Pras E, Bouma J. The importance of the groin node status for the survival of T1 ad T2 vulval carcinoma patients. Gynecol Oncol. 1995;57:327–34.PubMed

49.

Sideri M, De Cicco C, Maggioni A, Colombo N, Bocciolone L, Trifirò G, et al. Detection of sentinel nodes by lymphoscintigraphy and gamma probe guided surgery in vulvar neoplasia. Tumori. 2000;86:359–63.PubMed

50.

Levenback C, Coleman RL, Burke TW, Bodurka-Bevers D, Wolf JK, Gershenson DM. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol. 2001;83:276–81.PubMed

51.

Sliutz G, Reinthaller A, Lantzsch T, Mende T, Sinzinger H, Kainz C, et al. Lymphatic mapping of sentinel nodes in early vulvar cancer. Gynecol Oncol. 2002;84:449–52.PubMed

52.

Vidal-Sicart S, Puig-Tintoré LM, Lejárcegui JA, Paredes P, Ortega ML, Muñoz A, et al. Validation and application of the sentinel lymph node concept in malignant vulvar tumours. Eur J Nucl Med Mol Imaging. 2007;34:384–91.PubMed

53.

Johann S, Klaeser B, Krause T, Mueller MD. Comparison of outcome and recurrence-free survival after sentinel lymph node biopsy and lymphadenectomy in vulvar cancer. Gynecol Oncol. 2008;110:324–8.PubMed

54.

Hampl M, Hantschmann P, Michels W, Hillemanns P; German Multicenter Study Group. Validation of the accuracy of the sentinel lymph node procedure in patients with vulvar cancer: results of a multicenter study in Germany. Gynecol Oncol. 2008;111:282–8.PubMed

55.

Moore RG, Robison K, Brown AK, DiSilvestro P, Steinhoff M, Noto R, et al. Isolated sentinel lymph node dissection with conservative management in patients with squamous cell carcinoma of the vulva: a prospective trial. Gynecol Oncol. 2008;109:65–70.PubMed

56.

Van der Zee AG, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26:884–9.PubMed

57.

Lindell G, Jonsson C, Ehrsson RJ, Jacobsson H, Danielsson KG, Källström BN, et al. Evaluation of preoperative lymphoscintigraphy and sentinel node procedure in vulvar cancer. Eur J Obstet Gynecol Reprod Biol. 2010;152:91–5.PubMed

58.

Radziszewski J, Kowalewska M, Jedrzejczak T, Kozlowicz-Gudzinska I, Nasierowska-Guttmejer A, Bidzinski M, et al. The accuracy of the sentinel lymph node concept in early stage squamous cell vulvar carcinoma. Gynecol Oncol. 2010;116:473–7.PubMed

59.

Levenback CF, Ali S, Coleman RL, Gold MA, Fowler JM, Judson PL, et al. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol. 2012;30:3786–91.PubMedCentralPubMed

60.

Hefler LA, Grimm C, Six L, Seebacher V, Polterauer S, Joura E, et al. Inguinal sentinel lymph node dissection vs. complete inguinal lymph node dissection in patients with vulvar cancer. Anticancer Res. 2008;28:515–7.PubMed

61.

Oonk MH, van Hemel BM, Hollema H, de Hullu JA, Ansink AC, Vergote I, et al. Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol. 2010;11:646–52.PubMed

62.

Dhar KK, Das N, Brinkmann DA, Beynon JL, Wollas RP. Utility of sentinel node biopsy in vulvar and vaginal melanoma: report of two cases and review of the literature. Int J Gynecol Cancer. 2007;17:720–3.PubMed

63.

Descheemaeker V, Garin E, Morcel K, Lesimple T, Burtin F, Levêque J. Radioisotopic location of the sentinel node in vaginal mucous melanoma before laparoscopic sampling. Surg Laparosc Endosc Percutan Tech. 2008;18:195–6.PubMed

64.

van Dam P, Sonnemans H, van Dam PJ, Verkinderen L, Dirix LY. Sentinel node detection in patients with vaginal carcinoma. Gynecol Oncol. 2004;92:89–92.PubMed

65.

Cass I, Li AJ, Runowicz CD, Fields AL, Goldberg GL, Leuchter RS, et al. Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas. Gynecol Oncol. 2001;80:56–61.PubMed

66.

Negishi H, Takeda M, Fujimoto T, Todo Y, Ebina Y, Watari H, et al. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer. Gynecol Oncol. 2004;94:161–6.PubMed

67.

Nyberg RH, Korkola P, Mäenpäa J. Ovarian sentinel node. Is it feasible? Int J Gynecol Cancer. 2011;21:568–72.PubMed

68.

Trifirò G, Travaini LL, Sanvito F, Pacifici M, Mallia A, Ferrari ME, et al. Sentinel node detection by lymphoscintigraphy and sentinel lymph node biopsy in vulvar melanoma. Eur J Nucl Med Mol Imaging. 2010;37:736–41.PubMed

69.

Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans EF, Boom RP, et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloid albumin in breast cancer. J Nucl Med. 1997;38:366–8.PubMed

70.

Lavoué V, Bats AS, Rouzier R, Coutant C, Barranger E, Daraï E. Sentinel lymph node procedure followed by laparoscopic pelvic and paraaortic lymphadenectomy in women with IB2-II cervical cancer. Ann Surg Oncol. 2007;14:2654–61.PubMed

71.

Bats AS, Mathevet P, Buenerd A, Orliaguet I, Mery E, Zerdoud S, et al. The sentinel node technique detects unexpected drainage pathways and allows nodal ultrastaging in early cervical cancer: insights from the multicenter prospective SENTICOL study. Ann Surg Oncol. 2013;20:413–22.PubMed

72.

NEMA. NU 1 2001: Performance measurements of scintillation cameras. Rosslyn: National Electrotechnical Manufacturers Association; 2001. http://www.nema.org/stds/nu1.cfm.

73.

International Electrotechnical Commission. Nuclear medicine instrumentation – routine tests – part 2: scintillation cameras and single photon emission computed tomography imaging. IEC/TR 61948-2 ed. 1.0. Geneva: IEC; 2001.

74.

NEMA. NU 3 2004: Performance measurements and quality control guidelines for non-imaging intraoperative gamma probes. Rosslyn: National Electrotechnical Manufacturers Association; 2004 http://www.nema.org/stds/nu3.cfm.

75.

Wilhelm AJ, Mijnhout GS, Franssen EJF. Radiopharmaceuticals in sentinel lymph-node detection – an overview. Eur J Nucl Med. 1999;26:S36–42.PubMed

76.

Mariani G, Moresco I, Viale G, Villa G, Bagnasco M, Canavese G, et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med. 2001;42:1198–215.PubMed

77.

Gray RJ, Pockaj BA, Roarke MC. Injection of 99mTc-labeled sulfur colloid the day before operation for breast cancer sentinel lymph node mapping is as successful as injection the day of operation. Am J Surg. 2004;188:685–9.PubMed

78.

De Cicco C, Cremonesi M, Luini A, Bartolomei M, Grana C, Prisco G, et al. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med. 1998;39:2080–4.PubMed

79.

El-Ghobashy AE, Saidi SA. Sentinel lymph node sampling in gynaecological cancers: techniques and clinical applications. Eur J Surg Oncol. 2009;35:675–85.PubMed

80.

Holub Z, Jabor A, Kliment L. Comparison of two procedures for sentinel lymph node detection in patients with endometrial cancer: a pilot study. Eur J Gynaecol Oncol. 2002;23:53–7.PubMed

81.

Vidal-Sicart S, Doménech B, Luján B, Pahisa J, Torné A, Martínez-Román S, et al. Sentinel node in gynaecological cancers. Our experience. Rev Esp Med Nucl. 2009;28:221–8.PubMed

82.

Ballinger JR. Effect of increased 99mTc/99Tc ratios on count rates in sentinel node procedures: a randomised study. Eur J Nucl Med Mol Imaging. 2004;31(2):306.PubMed

83.

Vermeeren L, van der Ploeg IM, Olmos RA, Meinhardt W, Klop WM, Kroon BB, et al. SPECT/CT for preoperative sentinel node localization. J Surg Oncol. 2010;101:184–90.PubMed

84.

Keidar Z, Israel O, Krausz Y. SPECT/CT in tumor imaging: technical aspects and clinical applications. Semin Nucl Med. 2003;33:205–18.PubMed

85.

Martínez A, Zerdoud S, Mery E, Bouissou E, Ferron G, Querleu D. Hybrid imaging by SPECT/CT for sentinel lymph node detection in patients with cancer of the uterine cervix. Gynecol Oncol. 2010;119:431–5.PubMed

86.

Zhang WJ, Zheng R, Wu LY, Li XG, Chen SZ. Clinical application of sentinel lymph node detection to early stage cervical cancer. Ai Zheng. 2006;25:224–8.PubMed

87.

Pandit-Taskar N, Gemignani ML, Lyall A, Larson SM, Barakat RR, Abu Rustum NR. Single photon emission computed tomography SPECT-CT improves sentinel node detection and localization in cervical and uterine malignancy. Gynecol Oncol. 2010;117:59–64.PubMed

88.

Kim W, Menda Y, Willis J, Bartel TB, Graham MM. Use of lymphoscintigraphy with SPECT/CT for sentinel node localization in a case of vaginal melanoma. Clin Nucl Med. 2006;31:201–2.PubMed

89.

Kobayashi K, Ramirez PT, Kim EE, Levenback CF, Rohren EM, Frumovitz M, et al. Sentinel node mapping in vulvovaginal melanoma using SPECT/CT lymphoscintigraphy. Clin Nucl Med. 2009;34:859–61.PubMed

90.

Scherer K, Studer W, Figueiredo V, Bircher AJ. Anaphylaxis to isosulfan blue and cross-reactivity to patent blue V: case report and review of the nomenclature of vital blue dyes. Ann Allergy Asthma Immunol. 2006;96:497–500.PubMed

91.

van de Lande J, Torrenga B, Raijmakers PG, Hoekstra OS, van Baal MW, Brölmann HA, et al. Sentinel lymph node detection in early stage uterine cervix carcinoma: a systematic review. Gynecol Oncol. 2007;106:604–13.PubMed

92.

Marnitz S, Köhler C, Bongardt S, Braig U, Hertel H, Schneider A; German Association of Gynecologic Oncologists (AGO). Topographic distribution of sentinel lymph nodes in patients with cervical cancer. Gynecol Oncol. 2006;103:35–44.PubMed

93.

Zanzonico P, Heller S. The intraoperative gamma probe: basic principles and choices available. Semin Nucl Med. 2000;1:33–48.

94.

International Electrotechnical Commission. Medical electrical equipment – part 1: general requirements for safety. IEC 60101-1. (1988-12). Geneva: IEC; 1988.

95.

Waddington WA, Keshtgar MR, Taylor I, Lakhani SR, Short MD, Ell PJ. Radiation safety of the sentinel lymph node technique in breast cancer. Eur J Nucl Med. 2000;27:377–91.PubMed

96.

Michel R, Hofer C. Radiation safety precautions for sentinel lymph node procedures. Health Phys. 2004;86:S35–7.PubMed

97.

Schauer AJ, Becker W, Reiser M, Possinger G. The sentinel lymph node concept. Berlin: Springer; 2005. p. 5–9.

98.

Even-Sapir E, Lerman H, Lievshitz G, Khafif A, Fliss DM, Schwartz A, et al. Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system. J Nucl Med. 2003;44:1413–20.PubMed

99.

ICRP. ICRP Publication 84: Pregnancy and medical radiation. Amsterdam: Elsevier; 2000.

100.

Keleher A, Wendt III R, Delpassand E, Stachowiak AM, Kuerer HM. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J. 2004;10:492–5.PubMed

101.

Gentilini O, Cremonesi M, Trifiro G, Ferrari M, Baio SM, Caracciolo M, et al. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol. 2004;15:1348–5.PubMed

102.

Spanheimer PM, Graham MM, Sugg SL, Scott-Conner CE, Weigel RJ. Measurement of uterine radiation exposure from lymphoscintigraphy indicates safety of sentinel lymph node biopsy during pregnancy. Ann Surg Oncol. 2009;16(5):1143–7.PubMed

103.

Nejc D, Wrzesien M, Piekarski J, Olszewski J, Pluta P, Kusmierek J, et al. Sentinel node biopsy in skin melanoma patients – measurements of absorbed doses of radiation to the hands of medical staff. J Surg Oncol. 2006;93:355–61.PubMed

104.

Klausen TL, Chakera AH, Friis E, Rank F, Hesse B, Holm S. Radiation doses to staff involved in sentinel operations for breast cancer. Clin Physiol Funct Imaging. 2005;25:196–202.PubMed

105.

Sera T, Mohos G, Papos M, Osvay M, Varga J, Lazar M, et al. Sentinel lymph node detection in melanoma patients. Radiation safety considerations. Dermatol Surg. 2009;23:141–5.

106.

Nugent N, Hill AD, Casey M, Kelly L, Dijkstra B, Collins CD, et al. Safety guidelines for radiolocalised sentinel node resection. Ir J Med Sci. 2001;170:236–8.PubMed

107.

Zaknun JJ, Giammarile F, Olmos RA, Vidal-Sicart S, Mariani G. Changing paradigms in radioguided surgery and intraoperative imaging: the GOSTT concept. Eur J Nucl Med Mol Imaging. 2012;39:1–3.PubMed

Titel: The EANM clinical and technical guidelines for lymphoscintigraphy and sentinel node localization in gynaecological cancers
verfasst von: Francesco Giammarile
M. Fani Bozkurt
David Cibula
Jaume Pahisa
Wim J. Oyen
Pilar Paredes
Renato Valdes Olmos
Sergi Vidal Sicart
Publikationsdatum: 01.07.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 7/2014
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-014-2732-8

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

The EANM clinical and technical guidelines for lymphoscintigraphy and sentinel node localization in gynaecological cancers

Abstract

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2014

PET imaging reveals brain functional changes in internet gaming disorder

Treatment outcomes of patients with cervical cancer with complete metabolic responses after definitive chemoradiotherapy

PET/CT imaging and the oligometastatic prostate cancer patient: an opportunity for a curative approach with high-dose radiotherapy?

From Homo sapiens to Homo in nexu (connected man): could functional imaging redefine the brain of a “new human species”?

Combined SPECT/CT improves detection of initial bone invasion and determination of resection margins in squamous cell carcinoma of the head and neck compared to conventional imaging modalities

Prospective evaluation of 68Ga-DOTANOC PET-CT in differentiated thyroid cancer patients with raised thyroglobulin and negative 131I-whole body scan: comparison with 18F-FDG PET-CT